# Psilocybin Therapy for Depression in Bipolar II Disorder

> **NCT05065294** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 14 (estimated)

## Conditions studied

- Bipolar II Disorder

## Interventions

- **DRUG:** Psilocybin therapy

## Key facts

- **NCT ID:** NCT05065294
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-28
- **Primary completion:** 2024-08-01
- **Final completion:** 2025-07
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05065294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05065294, "Psilocybin Therapy for Depression in Bipolar II Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05065294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*